Consortium led by Evotec enters obesity drug space

Drug discovery CRO Evotec SE announced has entered into a partnership with Inserm, Lille University Hospital and Inserm Transfert to screen new biomarkers and targets in obesity and metabolic diseases.<br […]

Semarion Ltd. wins Ignite SME award at SLAS Europe

UK-based Semarion Ltd. was honoured as the most innovative company in the field of laboratory automation at SLAS Europe 2024 in Barcelona. <br /><br /><br />

MSD grabs Eyebiotech Ltd for US$1.3bn upfront

US pharma giant Merck Sharp &amp; Dohme (MSD) is decided to acquire London-based ophtalmology expert Eyebiotech Ltd for upt to US$3bn., US$1.7bn in future milestones. <div></div>

SLAS Europe 2024 honours products with most impact

Swiss Seed Biosciences SA and UK-based Cryologyx Ltd have won the SLAS Europe Product Award 2024 for product developments with transformational potential for the sector.

Hornet Therapeutics reports first data of EBV-triggered disease blocker

Hornet Therapeutics Ltd will use a US$5m seed financing to launch clinical tests of its IDO1 blocker HTX-201within the next 12 to 18 months to target post-transplant lymphoproliferative disease.

AstraZeneca puts step into lucrative obesity market

Swiss obesity start up SixPeaks Bio AG has made a good start, announcing a US$30m Series A financing led by Versant Ventures and a US$80m biobucks partnership with AstraZeneca plc.

AstraZeneca puts step into obesity market

Swiss obesity start up SixPeaks Bio AG has made a good start, announcing a US$30m Series A financing led by Versant Ventures and a US$80m biobucks partnership with AstraZeneca plc.

Seed financing for Cellugy A/S

Danish industrial biotechnology startup Cellugy raises €4,9m with the ambition to replace petrochemicals in personal care products.<br /><br /><br />

Obesity: Roche with first clinical data after US$2.7bn deal

Obesity candidate CT-388, which Genentech added to Roche's pipeline with the acquisition of Carmot Therapeutics, is at least not a disappointment, according to new trial data.<br /><br />